×

img Accessibility Controls

Technologies Banner

All Technologies

mRNA vaccine technology

Implementing Organization

Gennova, Pune

Project Overview

DBT-BIRAC supported India's first thermostable mRN vaccine to prevent COVID-19 by Gennova Pharmaceuticals limited

Benefits

Thermostable mRNA vaccine platform technology is empowering inida for pandemic preparedness
Funding Organization
Quick Information
Thrust Areas
Life Sciences & Biotechnology
Focus Area
Vaccines, Infectious Diseases
Status
Market authorization is received for COVID 19 and Omicron specific Covid 19 vaccine
Output
Status
Market authorization is received for COVID 19 and Omicron specific Covid 19 vaccine
TRL: Technology Readiness Level
TRL-9
Patent
Filed
arrowtop
Latest Updates
Loading…